Clinical Trial Update: Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial updates discuss the use of radioactive iodine for papillary thyroid carcinoma and the treatment decisions arising from the results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma

Drugs mentioned

• Radioactive iodine therapy (Iodine-131) (Iodine-131)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Thyroid Cancer | Phase 2, Phase 3 | Status: COMPLETED